Jawad A. Qureshi MDOctober 21, 2020

FDA 483 - Jawad A. Qureshi MD - October 21, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jawad A. Qureshi MD

Record Details

An FDA inspection of Jawad A. Qureshi MD in Grapevine, TX, revealed a significant deviation from the investigational plan during a clinical trial. The firm incorrectly administered investigational product to a study subject, necessitating an unscheduled follow-up visit. This indicates a failure to conduct the investigation in accordance with the signed statement of investigator and the approved plan.

Company: Jawad A. Qureshi MD
Inspection Date: October 21, 2020
Product Type: Other
Office: Division of Human and Animal Food Operations - West III
Person: Alanna L. Mussawwir-Bias (Assistant Country Director, Regulatory Specialist BIMO)

Open in Dashboard

ID · ff67daf8-7d9a-4948-a3d1-252feaa97638